60 Degrees Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.28 | -$2.28 | -$2.28 |
| Q2 2024 | 1 | -$4.24 | -$4.24 | -$4.24 |
| Q3 2024 | 1 | -$0.71 | -$0.71 | -$0.71 |
| Q4 2024 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q1 2025 | 1 | -$0.84 | -$0.84 | -$0.84 |
| Q2 2025 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q3 2025 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q4 2025 | 1 | -$0.63 | -$0.63 | -$0.63 |
60 Degrees Pharmaceuticals, Inc. Earnings Date And Information
60 Degrees Pharmaceuticals, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-4.23 earnings per share for the quarter, missing analysts' consensus estimates of $-3.96 by $0.27. The company had revenue of 135,293 for the quarter and had revenue of 253,573 for the year. 60 Degrees Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.95 diluted earnings per share) and currently has a price-to-earnings ratio of -0.27. 60 Degrees Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based on prior year's report dates.
60 Degrees Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.88 | $250,000 | $135,293 | ||
| 08/14/2024 | Q2 2024 | -$3.96 | -$4.23 | -0.27 | $100,000 | $125,700 |
| 05/15/2024 | Q1 2024 | -$1.92 | $0.04 | 1.96 | $146,094 | |
| 04/01/2024 | Q4 2023 | -$3.24 | -$0.34 | 2.9 | $42,707 | |
| 11/20/2023 | Q3 2023 | -$3.12 | $0.72 | 3.84 | $100,000 | $51,188 |
| 08/25/2023 | Q2 2023 | -$0.58 | $59,532 | |||
| 03/31/2023 | Q1 2023 | -$0.47 | $17,172 | |||
| 12/31/2022 | Q4 2022 | -$0.35 | $-75,652 | |||
| 09/29/2022 | Q3 2022 | -$0.26 | $168,185 | |||
| 06/29/2022 | Q2 2022 | -$0.39 | $45,173 | |||
| 03/31/2022 | Q1 2022 | -$0.16 | $47,024 | |||
| 12/31/2021 | Q4 2021 | -$0.23 | $29,464 |
60 Degrees Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is 60 Degrees Pharmaceuticals, Inc.'s earnings date?
60 Degrees Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.
-
How can I listen to 60 Degrees Pharmaceuticals, Inc.'s earnings conference call?
The conference call for 60 Degrees Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read 60 Degrees Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for 60 Degrees Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does 60 Degrees Pharmaceuticals, Inc. generate each year?
60 Degrees Pharmaceuticals, Inc. (:SXTP) has a recorded annual revenue of $253,573.
-
How much profit does 60 Degrees Pharmaceuticals, Inc. generate each year?
60 Degrees Pharmaceuticals, Inc. (:SXTP) has a recorded net income of $253,573. 60 Degrees Pharmaceuticals, Inc. has generated $-0.95 earnings per share over the last four quarters.
-
What is 60 Degrees Pharmaceuticals, Inc.'s price-to-earnings ratio?
60 Degrees Pharmaceuticals, Inc. (:SXTP) has a price-to-earnings ratio of -0.27 and price/earnings-to-growth ratio is 0.01.
